US to buy 10 million antiviral COVID-19 pills from Pfizer

Published



The U.S. government will purchase 10 million Pfizer pills that will help mitigate the symptoms of COVID-19 and potentially prevent hospitalization.

Pfizer announced Thursday it had signed an agreement with the United States to supply 10 million treatments of its COVID antiviral pill, Paxlovid, in exchange for $5 billion, once the Food and Drug Administration has approved the antiviral treatment.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.